HEADER DNA 18-NOV-13 2MH6 TITLE SOLUTION STRUCTURE OF DNA DUPLEX CONTAINING N3T-ETHYLENE-N1I TITLE 2 INTERSTRAND CROSS-LINK COMPND MOL_ID: 1; COMPND 2 MOLECULE: 5'-D(*CP*AP*GP*TP*TP*CP*CP*A)-3'; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: 5'-D(*TP*GP*GP*AP*IP*CP*TP*G)-3'; COMPND 7 CHAIN: B; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 MOL_ID: 2; SOURCE 4 SYNTHETIC: YES KEYWDS DNA DUPLEX, INTERSTRAND CROSS-LINK, DNA EXPDTA SOLUTION NMR NUMMDL 11 MDLTYP MINIMIZED AVERAGE AUTHOR A.Y.DENISOV,D.K.O'FLAHERTY,A.M.NORONHA,C.J.WILDS REVDAT 3 14-JUN-23 2MH6 1 REMARK LINK REVDAT 2 10-SEP-14 2MH6 1 JRNL REVDAT 1 02-JUL-14 2MH6 0 JRNL AUTH D.K.O'FLAHERTY,A.Y.DENISOV,A.M.NORONHA,C.J.WILDS JRNL TITL NMR STRUCTURE OF AN ETHYLENE INTERSTRAND CROSS-LINKED DNA JRNL TITL 2 WHICH MIMICS THE LESION FORMED BY JRNL TITL 3 1,3-BIS(2-CHLOROETHYL)-1-NITROSOUREA. JRNL REF CHEMMEDCHEM V. 9 2099 2014 JRNL REFN ISSN 1860-7179 JRNL PMID 24931822 JRNL DOI 10.1002/CMDC.201402121 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.2 REMARK 3 AUTHORS : BRUNGER, ADAMS, CLORE, GROS, NILGES AND READ REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2MH6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-DEC-13. REMARK 100 THE DEPOSITION ID IS D_1000103612. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298; 273 REMARK 210 PH : 7.5; 7.5 REMARK 210 IONIC STRENGTH : 0.1; 0.1 REMARK 210 PRESSURE : AMBIENT; AMBIENT REMARK 210 SAMPLE CONTENTS : 0.5 MM 5' REMARK 210 -D(*CP*AP*GP*TP*TP*CP*CP*A)-3', 0.5 MM 5'-D(*TP*GP*GP*AP*IP*CP* REMARK 210 TP*G)-3', 0.5 MM ETHANE, 100% D2O; 0.5 MM 5'-D(*CP*AP*GP*TP*TP* REMARK 210 CP*CP*A)-3', 0.5 MM 5'-D(*TP*GP*GP*AP*IP*CP*TP*G)-3', 0.5 MM REMARK 210 ETHANE, 90% H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-1H NOESY; 2D 1H-1H TOCSY; REMARK 210 2D DQF-COSY; 2D 1H-31P HSQC REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ REMARK 210 SPECTROMETER MODEL : UNITY INOVA; VNMRS REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRPIPE, NMRVIEW, VNMRJ REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 25 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 11 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LEAST REMARK 210 RESTRAINT VIOLATIONS AND THE REMARK 210 LOWEST ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 19620 RELATED DB: BMRB DBREF 2MH6 A 1 8 PDB 2MH6 2MH6 1 8 DBREF 2MH6 B 9 16 PDB 2MH6 2MH6 9 16 SEQRES 1 A 8 DC DA DG DT DT DC DC DA SEQRES 1 B 8 DT DG DG DA EDI DC DT DG HET EDI B 13 36 HETNAM EDI 2'-DEOXY-1-(2-IODOETHYL)INOSINE FORMUL 2 EDI C12 H16 I N4 O7 P LINK N3 DT A 4 C11 EDI B 13 1555 1555 1.46 LINK O3' DA B 12 P EDI B 13 1555 1555 1.61 LINK O3' EDI B 13 P DC B 14 1555 1555 1.61 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1